Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II/III Clinical Study to Evaluate the Efficacy and Safety of Timolol Maleate Gel in the Treatment of Proliferating Superficial Infantile Hemangioma

NCT06677853 is registered in ClinicalTrials.gov with Auson Pharmaceuticals Inc. as lead sponsor.

NCT NCT06677853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06677853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II/III Clinical Study to Evaluate the Efficacy and Safety of Timolol Maleate Gel in the Treatment of Proliferating Superficial Infantile Hemangioma
Lead sponsor
Auson Pharmaceuticals Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
October 28, 2020
Completion date
June 21, 2022
Enrollment
168 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

infantile hemangioma